CTLA4 and infection: While the potentially beneficial immune responses identified in the current study (upregulation of CTLA-4 and tryptophan metabolism) appeared to only occur in the acute infection phase, previous research has identified favorable immune responses that persist into the chronic infection phase, raising the potential for hookworm therapy to deliver a prolonged benefit from a single dose.23